Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Change in Account Payables (2020 - 2025)

LifeStance Health (LFST) has disclosed Change in Account Payables for 6 consecutive years, with -$4.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 3623.53% to -$4.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.6 million, a 411.98% decrease, with the full-year FY2025 number at -$1.6 million, down 411.98% from a year prior.
  • Change in Account Payables was -$4.4 million for Q4 2025 at LifeStance Health, down from $3.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.6 million in Q4 2022 to a low of -$5.5 million in Q1 2023.
  • A 5-year average of $513888.9 and a median of -$98000.0 in 2024 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: surged 348.71% in 2023, then crashed 3623.53% in 2025.
  • LifeStance Health's Change in Account Payables stood at $5.2 million in 2021, then grew by 25.25% to $6.6 million in 2022, then plummeted by 126.79% to -$1.8 million in 2023, then surged by 93.23% to -$119000.0 in 2024, then plummeted by 3623.53% to -$4.4 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Change in Account Payables are -$4.4 million (Q4 2025), $3.1 million (Q3 2025), and -$200000.0 (Q2 2025).